Cargando…

Increasing Awareness for Peripheral Artery Disease through the Identification of Novel Biomarkers

Detalles Bibliográficos
Autores principales:	Li, Ben, Syed, Muzammil H., Qadura, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452703/ https://www.ncbi.nlm.nih.gov/pubmed/37627254 http://dx.doi.org/10.3390/biom13081189

Ejemplares similares

Angiogenesis-related proteins as biomarkers for peripheral artery disease
por: Li, Ben, et al.
Publicado: (2023)

Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease
por: Zamzam, Abdelrahman, et al.
Publicado: (2021)

Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

The prognostic capability of inflammatory proteins in predicting peripheral artery disease related adverse events
por: Li, Ben, et al.
Publicado: (2022)

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease
por: Azab, Sandi M., et al.
Publicado: (2020)

Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature
por: Khan, Hamzah, et al.
Publicado: (2023)

The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study
por: Arfan, Sara, et al.
Publicado: (2022)

Fatty acid binding protein 3 is associated with peripheral arterial disease
por: Syed, Muzammil H., et al.
Publicado: (2020)

Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study
por: Zamzam, Abdelrahman, et al.
Publicado: (2022)

Urinary neutrophil gelatinase-associated lipocalin (NGAL) can potentially predict vascular complications and reliably risk stratify patients with peripheral arterial disease
por: Ehsan, Mehroz, et al.
Publicado: (2022)

A Systematic Review of Interleukins as Diagnostic and Prognostic Biomarkers for Peripheral Artery Disease
por: Djahanpour, Niousha, et al.
Publicado: (2023)

The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
por: Li, Ben, et al.
Publicado: (2022)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease
por: Alsuwailem, Bader, et al.
Publicado: (2021)

Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients
por: Zamzam, Abdelrahman, et al.
Publicado: (2020)

Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy
por: Khan, Hamzah, et al.
Publicado: (2022)

Plasma complement component C2: a potential biomarker for predicting abdominal aortic aneurysm related complications
por: Feridooni, Tiam, et al.
Publicado: (2022)

Management of a Mycotic Aneurysm in a Patient with COVID-19: A Case Report
por: Syed, Muzammil H., et al.
Publicado: (2021)

Peripheral arterial disease in polymyalgia rheumatica
por: Borg, Frances A, et al.
Publicado: (2009)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Elucidation of the Diagnosis and Treatment of Peripheral Arterial Disease
por: Kim, Hyung Oh, et al.
Publicado: (2018)

“Obesity and Lean Paradox” in Peripheral Artery Disease
por: Lee, Seung Hun, et al.
Publicado: (2021)

Clinical Decision Support for Peripheral Artery Disease: Answering the Call
por: Monteleone, Peter P., et al.
Publicado: (2018)

MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia
por: Syed, Muzammil H., et al.
Publicado: (2020)

Perceived Challenges to Routine Uptake of the Ankle Brachial Index within Primary Care Practice
por: Chiu, Lily Y. C., et al.
Publicado: (2021)

Novel paradigms of macrophage biology and function: identification of disease biomarkers and therapeutic targets
por: Wang, Diane Catherine, et al.
Publicado: (2022)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
por: Khan, Hamzah, et al.
Publicado: (2021)

Increasing the awareness of delirium in critically ill patients
por: Salluh, Jorge Ibrain de Figueira, et al.
Publicado: (2013)

Increasing awareness of sepsis: World Sepsis Day
por: Vincent, Jean-Louis
Publicado: (2012)

OSAS: its burden increases, not enough the awareness
por: Sanna, Antonio, et al.
Publicado: (2018)

Electronic cigarettes and vaping: toxicological awareness is increasing
por: Bolt, Hermann M.
Publicado: (2020)

The Need for Translational Research to Advance Peripheral Artery Disease Management
por: Moxon, Joseph V., et al.
Publicado: (2015)

A new era of medical therapy for peripheral artery disease
por: Casella, Ivan Benaduce, et al.
Publicado: (2020)

Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease
por: Noordzij, Marjon J., et al.
Publicado: (2011)

Focus on Peripheral Biomarkers of Mental Disorders
por: Bartoli, Francesco, et al.
Publicado: (2022)

Balancing Weight Loss and Sarcopenia in Elderly Patients With Peripheral Artery Disease
por: Kokkinidis, Damianos G., et al.
Publicado: (2019)

Considerations for Patients With Peripheral Artery Disease During the COVID-19 Pandemic
por: Farhan, Serdar, et al.
Publicado: (2021)

The Role of Circulating Biomarkers in Peripheral Arterial Disease
por: Saenz-Pipaon, Goren, et al.
Publicado: (2021)

Low serum magnesium as a risk factor for peripheral artery disease in chronic kidney disease: an open verdict
por: de Borst, Martin H, et al.
Publicado: (2020)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lrdb56b25sa0buus1i6nkdqu0r